← SynDRA
PICEID
SynDRA canonical compound SYN0004847 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | ICAM1 | XDH |
|---|
| Mechanism of action | ICAM1 expression inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- ICAM1 expression inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- PTGS2
- ACE
- NPY1R
- HTR1A
- HTR2A
- HTR2B
- HTR2C
- HTR3A
- KCNH2
- KDM4E
- MAOA
- MAPK1
- MAPT
- MBNL1
- MC3R
- MLNR
- NR1I2
- ADORA1
- NR3C1
- OPRD1
- OPRK1
- OPRM1
- PDE3A
- PDE4D
- PGR
- POLB
- SLC29A1
- SLC6A2
- SLC6A3
- SLC6A4
- HRH3
- HRH2
- HRH1
- HDAC6
- ADORA2A
- ADORA3
- ADRA1A
- ADRA2A
- ADRA2B
- ADRA2C
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- ALR
- COMT
- DPOLB
- GAMT
- GNMT
- HNMT
- KCMB2
- NNMT
- PNMT
Cross-references
Synonyms
- polydatin
- polydotin peceid
- pieceid
- Resveratrol 3-.beta.-mono-d-glucoside
- (e)-piceid
- (e)-polydatin
- Polydatin
- Trans-piceid
- Trans-polydatin
- Polydatin, >=95% (HPLC)
- 3,4'-5-Trihydroxystilbene-3-beta-D-glucopyranoside
- trans-polydatin
- polydatin (usp-rs)
- XM261C37CQ
- Resveratrol 3-beta-mono-D-glucoside
- Trans-Piceid
- 3,4,5-Trihydroxystilbene-3-beta-monoglucoside
- 3,4,5-Tsg
- Resveratrol 3-O-beta-glucopyranoside
- resveratrol-3-O-beta-D-glucoside
- trans-resveratrol 3-beta-glucoside
- trans-resveratrol 3-beta-D-glucoside
- trans-resveratrol 3-O-beta-D-glucoside
- CHEBI:8198
- 3,4',5-trihydroxystilbene-3-beta-D-glucoside
- Polydatin (E)-
- polydatin, (E)-
- RefChem:58805
- Sooryehan Pure-Whitening
- Resveratrol 3-O-glucoside
- Sooryehan Pure-Whitening Essence
- Sooryehan Pure Whitening Spot Treatment
- 5,4'-dihydroxystilbene-3-O-beta-D-Glcp
- MFCD00210592
- (E/Z)-Piceid
- MLS001424114
- 3,5,4'-Trihydroxystilbene 3-glucoside
- SMR000466371
- Resveratrol 3-Glucoside
Look up PICEID in the interactive SynDRA portal →